Merus N.V. financial data

Symbol
MRUS on Nasdaq
Industry
Pharmaceutical Preparations
Location
Yalelaan 62, 3584 Cm Utrecht, Netherlands
State of incorporation
Netherlands
Fiscal year end
December 31
Former names
Merus B.V. (to 5/23/2016)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 528 % +10.4%
Debt-to-equity 33.4 % -25%
Return On Equity -44.1 % +20.9%
Return On Assets -33.1 % +14.3%
Operating Margin -435 % -11.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58.7 M shares +26.1%
Common Stock, Shares, Outstanding 58.7 M shares +26.6%
Entity Public Float 1.3 B USD +26.1%
Common Stock, Value, Issued 5.97 M USD +25.5%
Weighted Average Number of Shares Outstanding, Basic 58.1 M shares +25.4%
Weighted Average Number of Shares Outstanding, Diluted 58.1 M shares +25.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 38.3 M USD -11.7%
Research and Development Expense 144 M USD -8.22%
General and Administrative Expense 60.6 M USD +8.47%
Operating Income (Loss) -167 M USD +1.83%
Nonoperating Income (Expense) 21.7 M USD +20.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -145 M USD +4.45%
Income Tax Expense (Benefit) 4.75 M USD +1123%
Net Income (Loss) Attributable to Parent -150 M USD +1.57%
Earnings Per Share, Basic -2.73 USD/shares +18.5%
Earnings Per Share, Diluted -2.73 USD/shares +18.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 178 M USD +73.6%
Marketable Securities, Current 159 M USD +15%
Cash, Cash Equivalents, and Short-term Investments 287 M USD -25.2%
Accounts Receivable, after Allowance for Credit Loss, Current 58.7 M USD +1131%
Other Assets, Current 1.58 M USD -34.6%
Assets, Current 410 M USD +58.9%
Deferred Income Tax Assets, Net 277 K USD -88.3%
Property, Plant and Equipment, Net 11.3 M USD -15.3%
Operating Lease, Right-of-Use Asset 10.8 M USD -12.6%
Other Assets, Noncurrent 2.56 M USD -39.6%
Assets 498 M USD +47.1%
Accounts Payable, Current 7.49 M USD +50.2%
Employee-related Liabilities, Current 3.58 M USD +9.59%
Accrued Liabilities, Current 38.5 M USD +8.13%
Liabilities, Current 78.5 M USD +4.53%
Operating Lease, Liability, Noncurrent 9.85 M USD -15%
Liabilities 149 M USD +22.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -29.9 M USD -14.2%
Retained Earnings (Accumulated Deficit) -788 M USD -23.5%
Stockholders' Equity Attributable to Parent 349 M USD +60.6%
Liabilities and Equity 498 M USD +47.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -44.4 M USD -20.8%
Net Cash Provided by (Used in) Financing Activities 30.2 M USD +13797%
Net Cash Provided by (Used in) Investing Activities -12.1 M USD -43.7%
Common Stock, Shares Authorized 67.5 M shares 0%
Common Stock, Shares, Issued 58.7 M shares +26.6%
Common Stock, Par or Stated Value Per Share 0.09 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -26.1 M USD +42.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 179 M USD +73.2%
Deferred Tax Assets, Valuation Allowance 173 M USD +33.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.26 pure 0%
Deferred Tax Assets, Gross 177 M USD +31.1%
Operating Lease, Liability 12.2 M USD -9.74%
Payments to Acquire Property, Plant, and Equipment 63 K USD -98.3%
Lessee, Operating Lease, Liability, to be Paid 14.4 M USD +14343%
Property, Plant and Equipment, Gross 19.9 M USD +14.2%
Operating Lease, Liability, Current 1.67 M USD +5.42%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.22 M USD +3.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.21 M USD -2.99%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 2.09 M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.28 M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.79 M USD -17.7%
Deferred Tax Assets, Operating Loss Carryforwards 162 M USD +46.3%
Deferred Federal Income Tax Expense (Benefit) 1.48 M USD
Current Income Tax Expense (Benefit) 2.65 M USD -0.86%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.56 M USD -9.71%
Operating Lease, Payments 2.17 M USD -26.9%
Current State and Local Tax Expense (Benefit) 797 K USD +1.66%
Current Federal Tax Expense (Benefit) 1.86 M USD -1.9%
Amortization of Intangible Assets 46 K USD -14.8%
Depreciation, Depletion and Amortization 561 K USD +5.06%
Deferred Tax Assets, Net of Valuation Allowance 4.2 M USD -22.3%
Share-based Payment Arrangement, Expense 25.3 M USD +1.27%
Deferred State and Local Income Tax Expense (Benefit) 613 K USD